Skip to main content
. Author manuscript; available in PMC: 2018 Aug 14.
Published in final edited form as: Handb Exp Pharmacol. 2018;245:227–247. doi: 10.1007/164_2017_65

Table 3.

Neuropathology and defects in COG-associated proteins

COG partners
ATP7A Menkes disease Early childhood neurodegeneration, severe neurologic impairment Zlatic et al. (2015)
GM130 Neurodegeneration Developmental delay, ataxia, decreased size of dendritic arbors Liu et al. (2017) and Zhou et al. (2014)
GS27 Myoclonus epilepsy/early ataxia Parkinson’s disease Lack muscle coordination, gait abnormality. Trafficking deficient cytotoxicity in NRK and PC12 cells Corbett et al. (2011) and Thayanidhi et al. (2010)
GS28 Neurodegeneration Retinal degeneration in D. melanogaster photoreceptors Rosenbaum et al. (2014)
Rab1a Parkinson’s disease sporadic ALS Neuroprotective in C. elegans, D. melanogaster, and rat neurons, rescue from the neurotoxic effects of α-Syn. Rab1 is misfolded and dysfunctional resulting in defective ER-Golgi trafficking Cooper et al. (2006), Gitler et al. (2008), and Soo et al. (2015)
Rab1b Alzheimer’s disease Dominant negative Rab1b blocks trafficking of APP and decreased the secretion of Ab Dugan et al. (1995)
Rab2 Parkinson’s disease Reduced expression of Rab2 rescues Golgi fragmentation in PD models Rendon et al. (2013)
Rab4a Neumann-Pick disease, Alzheimer’s disease, Down syndrome Developmental delays and dementia. Postmortem samples: Increased Rab4 in patients with AD and mild cognitive disorder. Aβ partially co-localizes with Rab4 in a mouse model of Down Syndrome Arriagada et al. (2010), Cataldo et al. (2000), Choudhury et al. (2004), and Ginsberg et al. (2010)
Rab6a Alzheimer’s disease Dominant negative mutant of Rab6 increased the secretion of sAPP and decreased Aβ secretion McConlogue et al. (1996)
Sec22b Parkinson’s disease Trafficking-deficient cytotoxicity in NRK and PC12 cells Hasegawa et al. (2003, 2004)
SNAP29 CEDNIK syndrome Cerebral dysgenesis, neuropathy, ichthyosis, and keratoderma Sprecher et al. (2005) and Fuchs-Telem et al. (2011)
STX5 Parkinson’s disease, neurodegeneration, Alzheimer’s disease Trafficking-deficient cytotoxicity in NRK and PC12 cells. Decreased STX5 causes accumulation and degradation of rhodopsin in D. melanogaster photoreceptors. Regulates processing of APP in PC12, HeLa, COS-7, and NG108–15 cell lines and hippocampal neurons, overexpressed STX5 coincides with accumulation of Aβ Rendon et al. (2013), Thayanidhi et al. (2010), Satoh et al. (2016), and Suga et al. (2005, 2015)
Vti1a/b Neurodegeneration Perinatal lethality in double knockouts mouse model. Neurodegenerative phenotypes: Major axon tracks are missing, reduced in size, or misrouted Kunwar et al. (2011) and Walter et al. (2014)
Ykt6 Parkinson’s disease Trafficking deficient cytotoxicity in NRK and PC12 cells Hasegawa et al. (2003, 2004)